ICICI Bank to donate Rs 1,200 crore to Tata cancer hospital

ICICI Bank will donate the money from its CSR funds to set up three new buildings over a cumulative area of 7.5 lakh square feet.

By: ENS Economic Bureau

Mumbai | Updated: June 2, 2023 07:24 PM IST

2 min read

"This is a step towards resolving a problem which we are foreseeing to aggravate, especially as urbanisation increases," Girish Chandra Chaturvedi told reporters at TMC's flagship hospital here after signing three Memorandums of Understanding for the centre. (file)

Listen to this article

Your browser does not support the audio element.

ICICI Bank Friday announced a commitment to contribute Rs 1,200 crore towards Tata Memorial Centre (TMC), a premier institution that runs cancer treatment and research centres across the country.

ICICI Bank will donate the money from its CSR funds to set up three new buildings over a cumulative area of 7.5 lakh square feet. It will equip them with state-of-the-art machines at TMC’s centres at Navi Mumbai in Maharashtra, Mullanpur in Punjab and Visakhapatnam in Andhra Pradesh. The bank’s CSR arm will implement the initiative, which is likely to be completed by 2027.

“With modern equipment and specialised multidisciplinary teams, these new centres of excellence in oncology treatment will provide advanced and evidence-based therapies to nearly 25,000 new patients a year, doubling the present capacity and providing a significant boost to the country’s cancer treatment infrastructure,” the bank said.

RA Badwe, Director, Tata Memorial Centre, said the radiation therapy block at ACTREC, Navi Mumbai will play a vital role in not only providing timely radiotherapy to a large number of patients, but will also be delivered with the most advanced techniques, both of which are critical for a successful outcome. Childhood and adult blood cancers are highly curable but require very intense therapies.

The ICICI centres being established at Visakhapatnam and Mullanpur are dedicated children and blood cancer centres and will provide state-of-the-art multidisciplinary care. These centres will soon become regional hubs offering advanced therapies such as bone marrow transplant and cellular therapies to patients from the region, Badwe said.

From the homepage